Epidemiologic Differentiation of Diagnostic and Screening Populations for the Assessment of Cervical Dysplasia Using Optical Technologies

Parkin, 2005, Global cancer statistics, 2002, CA Cancer J Clin, 55, 74, 10.3322/canjclin.55.2.74 Walboomers, 1999, Human papillomavirus is a necessary cause of invasive cervical cancer worldwide, J Pathol, 189, 12, 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F Gustafsson, 1997, International incidence rates of invasive cervical cancer after introduction of cytological screening, Cancer Causes Control, 8, 755, 10.1023/A:1018435522475 Jemal, 2007 Insinga, 2004, The health care costs of cervical human papillomavirus-related disease, Am J Obstet Gynecol, 191, 114, 10.1016/j.ajog.2004.01.042 Brewer, 2001, Fluorescence spectroscopy for in vivo characterization of ovarian tissue, Lasers Surg Med, 29, 128, 10.1002/lsm.1098 Mirabal, 2002, Reflectance spectroscopy for in vivo detection of cervical precancer, J Biomed Opt, 7, 587, 10.1117/1.1502675 Bosch, 1997, Human papillomavirus and other risk factors for cervical cancer, Biomed Pharmacother, 51, 268, 10.1016/S0753-3322(97)83542-1 Resnick R, Cornelissen M, Wright D, et al. Detection and typing of human papillomavirus in archival cervical cancer specimens by DNA amplification with consensus primers. J Natl Cancer Inst. 2018;82:1477–1484. Hosmer, 1989 Castellsagué, 2003, Cofactors in human papillomavirus carcinogenesis–role of parity, oral contraceptives, and tobacco smoking, J Natl Cancer Inst Monogr, 2003, 20, 10.1093/oxfordjournals.jncimonographs.a003477 Castle, 2003, Chapter 4: genital tract infections, cervical inflammation, and antioxidant nutrients-assessing their roles as human papillomavirus cofactors, J Natl Cancer Inst Monogr, 29, 10.1093/oxfordjournals.jncimonographs.a003478 Muñoz, 2002, Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study, Lancet, 359, 1093, 10.1016/S0140-6736(02)08151-5 Brinton, 1990, Oral contraceptive use and risk of invasive cervical cancer, Int J Epidemiol, 19, 4, 10.1093/ije/19.1.4 Daling, 1996, The relationship of human papillomavirus-related cervical tumors to cigarette smoking, oral contraceptive use, and prior herpes simplex virus type 2 infection, Cancer Epidemiol Biomarkers Prev, 5, 541 Kjellberg, 2000, Smoking, diet, pregnancy and oral contraceptive use as risk factors for cervical intra-epithelial neoplasia in relation to human papillomavirus infection, Br J Cancer, 82, 1332, 10.1054/bjoc.1999.1100 Moreno, 2002, Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study, Lancet, 359, 1085, 10.1016/S0140-6736(02)08150-3 Franco, 2001, Cervical cancer: epidemiology, prevention and the role of human papillomavirus infection, CMAJ, 164, 1017 Schoell, 1999, Epidemiology and biology of cervical cancer, Semin Surg Oncol, 16, 203, 10.1002/(SICI)1098-2388(199904/05)16:3<203::AID-SSU2>3.0.CO;2-C Saslow, 2002, American Cancer Society guideline for the early detection of cervical neoplasia and cancer, CA Cancer J Clin, 52, 342, 10.3322/canjclin.52.6.342 Gaarenstroom, 1994, Human papillomavirus DNA and genotypes: prognostic factors for progression of cervical intraepithelial neoplasia, Int J Gynecol Cancer, 4, 73, 10.1046/j.1525-1438.1994.04020073.x 1989, The 1988 Bethesda System for reporting cervical/vaginal cytologic diagnoses: developed and approved at a National Cancer Institute Workshop, Bethesda Maryland, U.S.A., December 12–13, 1988, J Reprod Med, 34, 779 Lee, 2007, A follow-up study of atypical squamous cells in gynecologic cytology using conventional Papanicolaou smears and liquid-based preparations: the impact of the Bethesda System 2001, Am J Clin Pathol, 127, 548, 10.1309/21U34K8YW053F21E Malpica, 2005, Kappa statistics to measure interrater and intrarater agreement for 1790 cervical biopsy specimens among twelve pathologists: qualitative histopathologic analysis and methodologic issues, Gynecol Oncol, 99, S38, 10.1016/j.ygyno.2005.07.040